Compound 1026
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)[C@H]1CCN(Cc2ccccc2-c2ccc(Cl)cc2)C[C@@H]1F
- InChi:
InChI=1S/C44H48ClF4N7O4S3/c1-54(2)21-18-33(28-61-34-9-4-3-5-10-34)52-39-17-16-35(24-42(39)62(57,58)44(47,48)49)63(59,60)53-43-37-19-23-56(27-40(37)50-29-51-43)41-20-22-55(26-38(41)46)25-31-8-6-7-11-36(31)30-12-14-32(45)15-13-30/h3-17,24,29,33,38,41,52H,18-23,25-28H2,1-2H3,(H,50,51,53)/t33-,38+,41+/m1/s1
- InChiKey:
DHYJRDDPIRPKOP-DOMFRNPMSA-N
External links
168317943 |
External search
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 66 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.44 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 945.26 g/mol | |||
HBA | 11 | |||
HBD | 2 | |||
HBA + HBD | 13 | |||
AlogP | 6.96 | |||
TPSA | 127.84 | |||
RB | 16 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 66 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 7.44 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4844 | Navitoclax | DB12340 | |
0.3861 | GDC-0349 | DB13072 | |
0.3818 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3800 | Sulfaisodimidine | DB13283 | |
0.3759 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.3666 | Presatovir | DB12165 | |
0.3555 | 4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE | DB04673 | |
0.3550 | Gemigliptin | DB12412 | |
0.3545 | Quinupristin | DB01369 | |
0.3531 | Sparsentan | DB12548 | |
0.3496 | Sulfametomidine | DB13485 | |
0.3482 | BMS-214662 | DB12234 | |
0.3443 | Lenacapavir | DB15673 | |
0.3426 | TAK-901 | DB12756 | |
0.3417 | N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide | DB01967 |